77 related articles for article (PubMed ID: 4459505)
21. Live attenuated varicella vaccine: the KMcC strain in healthy children.
Arbeter AM; Starr SE; Weibel RE; Neff BJ; Plotkin SA
Pediatrics; 1983 Mar; 71(3):307-12. PubMed ID: 6298698
[TBL] [Abstract][Full Text] [Related]
22. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
[TBL] [Abstract][Full Text] [Related]
23. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
24. Studies on the live attenuated rubella virus vaccine.
Nagashima T
Kitasato Arch Exp Med; 1973 Jun; 46(1):41-55. PubMed ID: 4210928
[No Abstract] [Full Text] [Related]
25. [Studies on rubella vaccination in adult females. I: Clinical and laboratory studies on clinical reactions].
Nakazono N
Hokkaido Igaku Zasshi; 1984 Mar; 59(2):180-91. PubMed ID: 6745839
[TBL] [Abstract][Full Text] [Related]
26. [Experience with vaccination with attenuated rubella vaccine (strain HPV-77 adapted to duck cells, 5th passage)].
Rocchi G; Salvadori A
Nuovi Ann Ig Microbiol; 1970; 21(4):336-40. PubMed ID: 5518412
[No Abstract] [Full Text] [Related]
27. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
[TBL] [Abstract][Full Text] [Related]
28. [1st French study of anti rubella vaccination with the attenuated Cendehill strain].
Lépine P; Zourbas J; Maurin J; Esmieu F
Bull Acad Natl Med; 1969; 153(13):248-57. PubMed ID: 4901672
[No Abstract] [Full Text] [Related]
29. [Distribution of anti-rubella virus antibodies in a female population sample of the community of Perugia and serological results of an anti-rubella vaccination experiment].
Iorio AM; Rivosecchi P; Fanelli M; Pitzurra M
Boll Ist Sieroter Milan; 1972; 51(5):405-9. PubMed ID: 4656955
[No Abstract] [Full Text] [Related]
30. [Vaccination against rubella].
Böttiger M
Lakartidningen; 1979 Oct; 76(41):3516-8. PubMed ID: 522538
[No Abstract] [Full Text] [Related]
31. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
Gerike E; Tischer A
Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
[TBL] [Abstract][Full Text] [Related]
32. [Experience in vaccination against rubella with the Cenderhill C-51 living and attenuated strain].
Nodari R; Saccani CF; Marangoni L; Fara GM; Galli MG; Bozzetti A; Tarantino F
G Mal Infett Parassit; 1970 Jan; 22(1):105-7. PubMed ID: 5420658
[No Abstract] [Full Text] [Related]
33. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
King SM; Saunders EF; Petric M; Gold R
Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367
[TBL] [Abstract][Full Text] [Related]
34. Studies on the live attenuated rubella virus vaccine. II. Research concerning attenuation of "Takahashi strain" isolated in Japan.
Owada Y; Yamane Y; Nagashima T; Adachi A; Ikumi H
Kitasato Arch Exp Med; 1973 Dec; 46(3-4):93-103. PubMed ID: 4218283
[No Abstract] [Full Text] [Related]
35. [Mumps epidemic in vaccinated children in West Switzerland].
Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D
Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835
[TBL] [Abstract][Full Text] [Related]
36. Vaccination of adult women with a Japanese rubella vaccine, QEF-passage Biken vaccine.
Nakazono N; Sawada H; Takebayashi T; Nakayama N; Ishii K; Kurosawa K; Miura R
Biken J; 1978 Sep; 21(3):111-3. PubMed ID: 749912
[No Abstract] [Full Text] [Related]
37. An extremely attenuated, live measles virus vaccine (CAM-EX). Persistence of low titer-antibody in institutionalized children with psychomotor retardation after vaccination.
Ueda K; Hashiguchi K; Nakashima F; Ueda S; Takahashi M
Biken J; 1981 Sep; 24(3):119-22. PubMed ID: 7337678
[TBL] [Abstract][Full Text] [Related]
38. [Rubella vaccination at the present time].
Angela GC
G Batteriol Virol Immunol Microbiol; 1973; 66(7-12):337-50. PubMed ID: 4802318
[No Abstract] [Full Text] [Related]
39. A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants.
Karron RA; Belshe RB; Wright PF; Thumar B; Burns B; Newman F; Cannon JC; Thompson J; Tsai T; Paschalis M; Wu SL; Mitcho Y; Hackell J; Murphy BR; Tatem JM
Pediatr Infect Dis J; 2003 May; 22(5):394-405. PubMed ID: 12792378
[TBL] [Abstract][Full Text] [Related]
40. Clinical and serologic evaluation of measles, mumps, and rubella (HPV-77:DE-5 and RA 27/3) virus vaccines, singly and in combination.
Lerman SJ; Bollinger M; Brunken JM
Pediatrics; 1981 Jul; 68(1):18-22. PubMed ID: 7017582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
